No Data
No Data
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Is Cogent Biosciences (NASDAQ:COGT) In A Good Position To Invest In Growth?
J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $23
Cogent Biosciences (COGT) Gets a Buy From J.P. Morgan